Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-05-02 @ 1:08 AM
Study NCT ID:
NCT03312751
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2017-10-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis
Sponsor:
Swedish Orphan Biovitrum
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NI-0501-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None